Medtech Talk

Butterfly Network CEO Laurent Faracci shares his experience leading a company through the Coronavirus outbreak, while producing lifesaving technology to battle the crisis. Laurent joined Butterfly as the Coronavirus spread to a global pandemic level, but he isn’t slowing down. Under his leadership, Butterfly continues to grow as their cutting-edge ultrasound technology proves itself a leading advancement in the fight against the Coronavirus in a time where leadership and innovation are essential to the future of healthcare. 

Joe Army’s career journey through the medtech industry has been anything but easy, but he does not back down from a challenge, and he’s sharing the greatest lessons that have helped him pave his own way. 

Medtech Talk welcomes its new host, Geoff Pardo! Geoff is a dynamic partner at Gilde Healthcare who uses his passion for medtech to share stories from industry leaders.  

In this interview, Murthy Simhambhatla, president and CEO of SetPoint Medical, explains why he moved into the Medtech industry and how that path has positioned him to lead SetPoint Medical, one of the industry’s most promising start-ups. 

In this episode, Mike Favet, the new CEO of NeuroPace, shares his personal story into Medtech and reveals his plans for one of Medtech’s pioneers, NeuroPace. What convinced him to become CEO? What changes will he make at NeuroPace?

In this interview, Frank Fischer and Martha Morrell, MD, recount the long history of NeuroPace, one of Medtech’s neurostimulation pioneers. 

In this episode of Medtech Talk, Duke Rohlen, CEO of AJAX Health, answers several critical questions about the importance of names. What’s his real name? Why is the AJAX name so important to him? And how did he employ “stair stepping” to make a name for himself in Medtech (before founding, funding and exiting several high profile start-ups.) 

Kim Rodriguez expected to follow her mom’s career in medicine. But she got bit by the Medtech Bug early and enjoyed a string of sales success at companies of nearly every size including Cocentric, Spectranetics, and Guidant. But three years ago she got recruited to be CEO of a company that was rich in promising technologies as well as business challenges. In just three years, Rodriguez and her team at Acessa pulled out of the tail spin, secured FDA approval and a CPT code and now are building a promising women’s health company. In this episode, she’ll share how aspiring execs should ante up. 

Justin Klein and Kirk Nielsen entered venture capital separately 13 years ago, taking roles at two of the top firms in Medtech. Over that time, the two VCs have led investment in more than a dozen Medtech companies that have either gone public or been acquired. Now, the pair have joined forces to create Vensana Capital, a new investor in Medtech. In this episode, you’ll hear why they decided to venture out on their own and where they’ll be investing $225 million in capital from their first fund.   

Growing up in Canada, Kevin Lobo only knew he wanted to be a senior executive at a global company someday. That overriding objective took him through the consumer good and chemical industries before the financial executive found his first job in Medtech. In this interview conducted at the Medtech Conference in Minneapolis, Lobo reveals that while he first was reluctant to take that Medtech job, he’s now grateful to have found a home. “If you’ve only been in Medtech, you do not understand how lucky you are to be in this industry.” Lobo shares insights on how he built a career that positioned him to lead one of Medtech’s giant. He also explains why under his watch Stryker grew to become a “serial acquirer” of that has spent $14 billion to acquire 55 companies during his tenure as CEO.